Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Syndromic Testing System, Respiratory Panel Garner FDA Clearance

NEW YORK (GenomeWeb) – Qiagen said today that its QiaStat-Dx syndromic testing system and multiplex respiratory pathogen panel have received 510(k) clearance from the US Food and Drug Administration.

With the clearance, Qiagen is commercially launching the products in the US, the company said.

The QiaStat-Dx system features multiplexed real-time PCR and can detect as many as 48 targets simultaneously, enabled by a proprietary microfluidic test cassette design and a six-wavelength optical sensor. The system will also be capable of running immunoassays using time-resolved fluorescence.

Qiagen acquired the technology along with Spanish molecular diagnostics company Stat-Dx in early 2018 for up to $191 million. The system and accompanying respiratory pathogen panel already had CE marking and is commercially available in Europe. A gastrointestinal pathogen panel is also available in Europe.

The QiaStat-Dx Respiratory Panel simultaneously and qualitatively detects and identifies more than 20 respiratory viral and bacterial pathogens. The panel is the first in a pipeline of planned assays for the QiaStat-Dx system in the US, with a gastrointestinal pathogen panel anticipated later this year. Qiagen said it is also developing assays for other infectious disease indications, oncology, and companion diagnostics.

"We are pleased to roll out the QiaStat-Dx Respiratory Panel for healthcare providers as they begin to prepare for the 2019-20 flu season," Thierry Bernard, senior vice president and head of Molecular diagnostics for Qiagen, said in a statement. 

In morning trading on the New York Stock Exchange Qiagen's shares were up nearly 4 percent to $38.41.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.